IHH Healthcare Berhad | Annual Report 2024 70 Governance Notes • Does not have any family relationships with any directors and/or any major shareholders of the Company • Does not have any conflict of interest with the Company • Does not have any convictions for offences within the past five years other than for traffic offences, if any Work Experience Dr Kenneth Tsang was appointed as Regional Chief Executive Officer, IHH Healthcare North Asia on 1 April 2024. He leads the development and drives operational and clinical excellence of IHH’s business operations in North Asia which include multi-specialty hospitals, networks of primary, specialist and surgical clinics, as well as ambulatory care centres in Shanghai and Hong Kong. His strategic leadership plays a pivotal role in advancing IHH’s integrated healthcare businesses in China towards sustainable and long-term growth. In conjunction with his regional role, Dr Tsang provides oversight for Gleneagles Hospital Hong Kong as Chief Executive Officer. He also provides leadership for the clinic network under Gleneagles Healthcare, ambulatory services under Gleneagles MediCentre, and Parkway Laboratory Services in Hong Kong. Dr Tsang also spearheads Gleneagles Clinical Trials Centre which contributes to healthcare innovation and advancement in Hong Kong and nearby regions. Prior to joining IHH, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician and later in management roles focused on patient safety, strategy and service planning, and infection control. Dr Tsang is an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong. Academic/Professional Qualification(s) • Bachelor of Medicine & Surgery, The University of Hong Kong • Master of Occupational Medicine, The Chinese University of Hong Kong • Fellow, Hong Kong Academy of Medicine (Community Medicine) • Fellow, Hong Kong College of Community Medicine • Fellow, The Royal Australasian College of Medical Administrators Dr Kenneth Tsang Regional Chief Executive Officer, IHH Healthcare North Asia Nationality: Chinese Gender: Male Age: 55 (As at 1 April 2025) Date of Appointment: 1 April 2024 Work Experience Mr Anurag Yadav joined Gleneagles Healthcare India as its Chief Financial Officer on 1 April 2017 before assuming the position of Chief Executive Officer on 14 January 2022. With more than 25 years of experience under his belt, Mr Yadav is an expert in business leadership, financial management, strategic planning, mergers and acquisitions and post-merger integration. Prior to IHH, Mr Yadav was the Regional Operations Head (North India) of Manipal Health Enterprises, responsible for its financial delivery, the commissioning of a greenfield project in the National Capital Region of India as well as its radiology joint venture with Philips. As a senior leader with Fortis Healthcare, he was involved in the listing of the company in 2007 as well as its subsequent rights issue in 2009. Mr Yadav was also part of the Fortis leadership team managing acquisitions and the effective integration of 10 Wockhardt, 4 Escorts and Malar Hospitals and 4 greenfield hospital projects. Academic/Professional Qualification(s) • Fellow Member, Institute of Chartered Accountants of India • Post graduate degree in Commerce, Himachal University, India • Bachelor of Law, Punjab University, India Anurag Yadav Chief Executive Officer, Gleneagles Healthcare India Nationality: Indian Gender: Male Age: 55 (As at 1 April 2025) Date of Appointment: 14 January 2022 Country Leadership
RkJQdWJsaXNoZXIy NDgzMzc=